openPR Logo
Press release

Life Sciences BPO Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024

02-13-2017 05:45 PM CET | Health & Medicine

Press release from: Life Sciences BPO Market

Life Sciences BPO Market- Global Industry Analysis, Size,

Life Sciences BPO Services – Helping healthcare companies improve ROI and upscale their business

The healthcare industry is characterized by high competition, increased cost pressure, and decreasing research and development (R&D) productivity, which is compelling pharmaceutical and biotech companies to make strategic collaborations and outsource their non-core activities. Pharmaceutical, biotech, and medical device players alike are outsourcing processes related to manufacturing, product research, and regulatory process services, among others to contract manufacturing and contract research organizations. This helps them to focus on their core strengths and in turn improve productivity. The global life sciences BPO market is analyzed for various service types such as medical device outsourcing, pharmaceutical outsourcing, and regulatory information. The global life sciences BPO market was valued at US$ 180.4 billion in 2015 and is expected to expand at a CAGR of 12.2% during the forecast period considered (2016 – 2024).

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/24

Life Science BPO Market

Source: Coherent Market Insights Analysis (2016)

Patent expirations to boost the prospects for life sciences BPO market

According to UBM India Pharma Publication, over US$ 40 billion worth of drug are expected to be off-patent in the U.S. by 2017. Also, in 2014, utilization of generic drugs resulted in savings of around US$ 254 billion in the U.S. This trend is anticipated to increase further with more patent expirations in the near future. This factor coupled with the advent of biosimilars is projected to boost demand for life science BPO services over the forecast period.

India home to second-highest number of U.S. FDA approved manufacturing facilities

Demand for contract manufacturing and contract research services in Asia is high, mainly due to large number of FDA approved drug manufacturing plants in this region. According to the UBM India Pharma Publication report of 2015, Indian accounts for 22% of the overall U.S. FDA approved drug manufacturing facilities globally. Moreover, dynamics such as wide availability of highly trained professionals, cheap labor, large patient pool, and easy availability of subjects for clinical trials are positioning Asia Pacific as a major market for life science BPO. The market in this region is expected to expand at a CAGR of 16.6% during the forecast period.

Uncertainty and differences in government regulations to increase demand for regulatory outsourcing services

Healthcare companies are subject to highly uncertain regulations that change according to country and changing government priorities. For instance, Section 3d of the Indian Pharma Act does not approve any new drug that is an altered form of a known molecule and not representing an improved efficacy over the existing molecule. While this drug is approved in the U.S., U.K, Australia and other countries. Dismissal of such patent applications discourages investment in countries with high growth potential. Also, mandatory licensing and patent ever-greening strategies further makes regulatory filing in a country more complex. Hence, healthcare companies hire regulatory experts of the respective countries to execute the regulatory process smoothly in that particular country.

Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/market-insight/life-sciences-bpo-market-24

Import and distribution of drug or medical devices in several countries require regulatory clearance that is efficiently managed by life science BPO companies. This enables pharmaceutical, biotech and medical device companies to focus on their core activities such as research, marketing, distribution agreements, and increasing product availability. The regulatory information segment is expected to grow swiftly to reach US$ 35 billion by 2024, on account of increasing abbreviated new drug application (ANDA) filings and growing interest in biosimilars.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Life Sciences BPO Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024 here

News-ID: 436002 • Views: 581

More Releases from Life Sciences BPO Market

Analysis of Life Sciences BPO Market in Global Industry : Market Development and …
Albany, NY, 29th March : Recent research and the current scenario as well as future market potential of "Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023" globally. The life sciences BPO market comprises services offered by CMOs (Contract Manufacturing Organizations) and CROs (Contract Research Organizations) to the biotech pharmaceutical companies. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=186978 A rise in demand
Life Sciences BPO Market - Analysis And Forecast (2016-2024): Market Shares And …
Life Sciences BPO Services – Helping healthcare companies improve ROI and upscale their business The healthcare industry is characterized by high competition, increased cost pressure, and decreasing research and development (R&D) productivity, which is compelling pharmaceutical and biotech companies to make strategic collaborations and outsource their non-core activities. Pharmaceutical, biotech, and medical device players alike are outsourcing processes related to manufacturing, product research, and regulatory process services, among others to contract
Life Sciences BPO Market - Analysis And Forecast (2016-2024): Market Shares And …
Life science business process outsourcing (BPO) is one of the most lucrative industries in the healthcare sector. Constantly rising pricing pressure and increasing competition is compelling pharmaceutical and medical device companies to strategically reduce their operational costs and in turn benefit from higher profits. This has led to an increasing demand for contract manufacturing outsourcing (CMO) and contract research outsourcing (CRO) services. Asia and Latin America are the most attractive
Life Sciences BPO Market, Company Analysis and Forecast to 2024
Life science business process outsourcing (BPO) is one of the most lucrative industries in the healthcare sector. Constantly rising pricing pressure and increasing competition is compelling pharmaceutical and medical device companies to strategically reduce their operational costs and in turn benefit from higher profits. This has led to an increasing demand for contract manufacturing outsourcing (CMO) and contract research outsourcing (CRO) services. Asia and Latin America are the most attractive

All 5 Releases


More Releases for Science

Data Analytics & Science
Amvion Analytica would focus on BI for SMB’s. This is a conscious targeting strategy as Amvion feels its approach capture the exact struggle that prevents SMB’s to get into analyzing their data. Beyond skills, business opportunity to explore BI for SMB’s does look easier & profitable than focusing on large customers NO: 1, 2nd street, Dr. Ranga Road, Alwarpet Chennai- 600 018 Amvion Labs Pvt Ltd., started in 2016, by a team who
Tissue Science 2019
Tissue Science 2019 is the fundamental event that joins an unprecedented and worldwide authorities, experts and chiefs both from the academic network and industry from wherever all through the world to exchange their knowledge, capacity and research progressions in the field of Tissue Science and Regenerative Medicine. Tissue Science 2019 gives a general stage to sharing information and considerations, late frameworks in Regenerative medication, Tissue engineering, Organ regeneration and freshest
Plant Science Conference 2018
Meetings International proudly announces the Global Experts Meeting on International Conference on Plant Science scheduled on October 25-27, 2018 in Paris, France, with a theme of “Explore the Scope of Plant Science". Meetings International (Meetings Int.) is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations,
Plant Science Conference 2018
Meetings International proudly announces the Global Experts Meeting on International Conference on Plant Science scheduled on October 25-27, 2018 in Paris, France, with a theme of “Explore the Scope of Plant Science". Meetings International (Meetings Int.) is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings Int. has been associated with national and international associations,
Bioelectronic Medicine: Science Fiction or Science Fact?
The resounding answer to the above question is, science fact! Bioelectronic Medicine is, and will continue to be, one of the fastest-growing industries, within the medical sector. BAC Medical Marketing has positioned itself perfectly to take full advantage of the rapid growth of Bioelectronic Medicine by offering a state-of-the-art device, and accompanying software, that has been used successfully by doctors on their patients throughout Europe and Asia for many years,
Science Gone Wrong: Welteislehre
What we classify as science is determined by the times we live in. That has been shown by a project of the Austrian Science Fund FWF on the phenomenon of Welteislehre (the Cosmic Ice Theory). At the start of the 20th century, a broad swathe of the general public believed in this now discredited theory of what the universe is made of and how it was created. The findings of